The Patent Finder

Terms ending in 2039

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,957,435Computer System and Method for Generating Trigger Alerts to Maximize Interactions with Healthcare Providers
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,420,984Arginase Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,912,727Arginase Inhibitors and Methods of Use Thereof
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 12,195,485Arginase Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,201,638Pharmaceutical Compositions Comprising (2S)-N-{(1S)-1-Cyano-2-[4-(3-Methyl-2-OXO-2,3-Dihydro-1,3-Benzoxazol-5-yl)PHENYL]ETHYL}-1,4- OXAZEPANE-2-Carboxamide
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,479,539Small Molecule Modulators of the BTB Domain of KEAP1
In force
 · Medium confidence
MedImmune LimitedIn forceMedium confidence
US 11,798,661Methods for Lowering Blood Pressure with a Dihydropyridine-Type Calcium Channel Blocker Pharmaceutical Composition
In force
 · High confidence
AstraZeneca UK LimitedIn forceHigh confidence
US 11,149,029Novel Salts of Ijak Inhibitors and Methods of Using the Same
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,826,376Methods of Treating Heart Failure with Preserved Ejection Fraction Employing Dapagliflozin and Compositions Comprising the Same
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,472,194Methods of Treating Heart Failure with Preserved Ejection Fraction Employing Dapagliflozin and Compositions Comprising the Same
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
3 more term ends in 2039 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
10 of these are in force and held by AstraZeneca AB.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited